期刊文献+

血清胱抑素C与脑白质病变的相关性研究 被引量:9

Association of cystatin C level with cerebral white matter lesions: clinical report of 473 cases
下载PDF
导出
摘要 目的探讨血清胱抑素C(Cystatin C,CysC)水平和脑白质病变(white matter lesions, WMLs)的相关性。方法收集2014年7月至2015年3月本科住院患者资料,胶体金免疫增强法检测血清CysC水平,颅脑MRI检查评估脑白质病变,采用Fazekas标准分别对患者脑室旁脑白质病变(P-WMLs)和深部脑白质病变(D-WMLs)的严重程度进行评价,危险因素的分析采用有序多分类Logistic回归分析。结果共473例患者纳入研究,男性190例,年龄(65.7±9.1)岁。重度(0.82±0.18)和中度P-WMLs患者(0.78±0.15)血清CysC水平均高于轻度P-WMLs患者(0.73±0.14),重度(0.82±0.18)和中度D-WMLs患者(0.79±0.16)血清CysC水平同样高于轻度D-WMLs患者(0.74±0.14),差异均有统计学意义(P〈0.05),二者均提示随着WMLs病变程度的增加CysC水平也越高。多因素有序多分类Logistic回归分析结果显示,高水平的CysC(P-WMLs:OR=8.21,95%CI=2.18~30.88;D-WMLs:OR=7.01,95%CI=1.69~29.11)、年龄(P-WMLs:OR=5.18,95%CI=2.81~9.55;D-WMLs:OR=4.32,95%CI=2.05~9.08)和高血压(P-WMLs:OR=3.46,95%CI=2.30~5.21;D-WMLs: OR=3.52,95%CI=2.21~5.62)均为WMLs严重程度增加的危险因素。结论血清CysC水平与WMLs病变程度呈正相关;高水平CysC、高龄及高血压是WMLs病变严重程度增加的危险因素。 Objective To determine the relationship between serum level of Cystatin C (CysC) and cerebral white matter lesions (WMLs). Methods The 50-year-old and older patients admitted in our department from July 2014 to March 2015 were prospectively recruited in this study. Colloidal gold immunoassay was used to determine their serum CysC level. MRI scanning was employed to identify WMLs, and Fazekas scale was used to grade the patients into periventricular WMLs (P-WMLs) and deep WMLs (D-WMLs) groups. Multivariate logistic regression analyses were performed to examine the association of CysC with WMLs. Results There were 190 males and 283 males, at a mean age of 65.7±9.1 in the cohort. In P-WMLs group, the CysC level was significantly higher in the severe and moderate groups than the mild group (0.82±0.18 and 0.78±0.15 vs 0.73±0.14 mg/L, P〈0.05). And in D-WMLs group, the level was also obviously higher in severe and moderate groups than the mild group (0.82±0.18 and 0.79±0.16 vs 0.74±0.14, P〈0.05). The results indicated that the severer MMLs was, the higher the CysC level was. Multivariate logistic regression analyses showed that CysC level (P-WMLs: OR=8.21, 95%CI:2.18~30.88; D-WMLs: OR=7.01, 95%CI: 1.69~29.11), age (P-WMLs: OR=5.18, 95%CI: 2.81~9.55; D-WMLs: OR=4.32, 95%CI: 2.05~9.08) and hypertension (P-WMLs: OR=3.46, 95%CI: 2.30~5.21; D-WMLs: OR=3.52, 95%CI: 2.21~5.62) were risk factors for the increased severity of WMLs. Conclusion CysC level is positively correlated with the severity of WMLs. Elevated CysC level, older age and hypertension are independent risk factors for increased severity of WMLs.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2016年第5期511-516,共6页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(81271282 81471193 81400967)~~
关键词 胱抑素C 脑白质病变 脑小血管病 cystatin C white matter lesions cerebral small vessel disease
  • 相关文献

参考文献24

  • 1Kim K W,MacFall J R,Payne M E. Classification of whitematter lesions on magnetic resonance imaging in elderly per-sons [J]. Biol Psychiatry, 2008,64(4) : 273 -280. DOI:10. 1016/j. biopsych. 2008. 03. 024.
  • 2Pantoni L. Cerebral small vessel disease: from pathogenesisand clinical characteristics to therapeutic challenges [ J ]. Lan-cet Neurol, 2010, 9(7) : 689 -701. DOI: 10. 1016/S1474-4422(10)70104-6.
  • 3Black S,Gao F,Bilbao J. Understanding white matter dis-ease: Imaging-pathological correlations in vascular cognitiveimpairment [ J]. Stroke, 2009,40(3 Suppl) : S48 — S52.DOI: 10.1161/STROKEAHA. 108.537704.
  • 4Tan G D, Lewis A V,James T J, ef al. Clinical usefulness ofcystatin C for the estimation of glomerular filtration rate intype 1 diabetes : reproducibility and accuracy compared withstandard measures and iohexol clearance[ J] . Diabetes care,2002,25(11) : 2004 - 2009. DOI: 10. 2337/diacare. 25.11.2004.
  • 5Dhamidharka V R,Kwon C,Stevens G. Serum cystatin C issuperior to serum creatinine as a marker of kidney function : ameta-analysis[ J]. Am J Kidney Dis, 2002,40(2) : 221 -226. DOI: 10, 1053/ajkd. 2002.34487.
  • 6Shlipak M G,Katz R,Samak M J, ei al. Cystatin C andprognosis for cardiovascular and kidney outcomes in elderlypersons without chronic kidney disease [ J ]. Ann Intern Med,2006,145(4) : 237 - 246. DOI: 10.7326/00034819-145-4-200608150-00003.
  • 7Stevens L A, Coresh J, Greene T, et al. Assessing kidneyfunction—measured and estimated glomerular filtration rate[J]. N Engl J Med, 2006, 354(23) : 2473-2483. DOI: 10.1056/NEJMra054415.
  • 8Shlipak M G, Samak M J, Katz R,et al. Cystatin C and therisk of death and cardiovascular events among elderly persons[J]. N Engl J Med, 2005, 352(20) : 2049-2060. DOI: 10.1056/NEJMoa043161.
  • 9Seliger S L, Longstreth W T Jr, Katz R, et al. Cystatin Cand subclinical brain infarction [ J ]. J Am Soc Nephrol,2005,16 ( 12 ): 3721-3727. DOI: 10. 1681/ASN.2005010006.
  • 10Yaffe K, Lindquist K, Shlipak MG, et al. Cystatin C as amarker of cognitive function in elders : findings from thehealth ABC study [ J] . Ann Neurol, 2008,63 (6): 798-802. DOI: 10. 1002/ana. 21383.

二级参考文献12

  • 1陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 2de Leeuw FE, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in el- derly people: a population based magnetic reso- nance imaging study. The Rotterdam Scan Study [J]. J Neurol Neurosurg Psychiatry, 2001, 70: 9-14.
  • 3O'Sullivan M. Leukoaraiosis [J]. PractNeurol, 2008, 8: 26-38.
  • 4Hachinski VC, Bowler J. Vassular Demen- tia//Ginsberg MD, Bogousslavsky J. Cerebrovas- cular Disease: Pathophysiology Diagnosis and Management [M]. Massachusetts: Blackwell Sci- ence, 1998: 1132-1134.
  • 5Wahlund LO, Barkhof F, Fazekas F, et al. A new rating scale for age-related white matter changes applicable to MRI and CT [J]. Stroke, 2001, 32: 1318-1322.
  • 6Guo X, Pantoni L, Simoni M, et al. Blood pressure components and changes in relation to white matter lesions: a 32-year prospective popu- lation study[J]. Hypertension, 2009, 54: 57-62.
  • 7A_nan F, Masaki T, Kikuchi H, et al. Associa- tion between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients [J]. Diabetes Research and Clinical Practice, 2010, 87: 233-239.
  • 8Shih CY, Chen CY, Wen C J, et al. Relation-ship between serum uric acid and cerebral white matter lesions in the elderly [J]. Nutr Metab Cardiovasc Dis, 2012, 22: 154-159.
  • 9Besga A, Cedazo-Minguez A, K,~eholt I, et al. Differences in brain cholesterol metabolism and insulin in two subgroups of patients with dif- ferent CSF biomarkers but similar white matter lesions suggest different pathogenic mechanisms [J]. Neurosci Lett, 2012, 510: 121-126.
  • 10Simon A, Gariepy J, Chironi G, et al. Inti- ma-media thickness: a new tool for diagnosis and treatment of cardiovascular risk [J]. J Hypertens, 2002, 20: 159-169.

共引文献3

同被引文献82

引证文献9

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部